Ikarian Capital »

Rapt Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 790k 25.79

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics